HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology.

Abstract
The "sphingosin" backbone of sphingolipids was so named by J. L. W. Thudichum in 1884 for its enigmatic ("Sphinx-like") properties. Although still an elusive class of lipids, research on the involvement of sphingolipids in the signal transduction pathways that mediate cell growth, differentiation, multiple cell functions, and cell death has been rapidly expanding our understanding of these compounds. In addition to the newly discovered role of ceramide as an intracellular second messenger for tumor necrosis factor-alpha, IL-1beta, and other cytokines, sphingosine, sphingosine-1-phosphate, and other sphingolipid metabolites have recently been demonstrated to modulate cellular calcium homeostasis and cell proliferation. Perturbation of sphingolipid metabolism using synthetic and naturally occurring inhibitors of key enzymes of the biosynthetic pathways is aiding the characterization of these processes; for examples, inhibition of cerebroside synthase has indicated a role for ceramide in cellular stress responses including heat shock, and inhibition of ceramide synthase (by fumonisins) has revealed the role of disruption of sphingolipid metabolism in several animal diseases. Fumonisins are currently the focus of a FDA long-term tumor study. This review summarizes recent research on (i) the role of sphingolipids as important components of the diet, (ii) the role of sphingoid base metabolites and the ceramide cycle in expression of genes regulating cell growth, differentiation, and apoptosis, (iii) the use of cerebroside synthase inhibitors as tools for understanding the role of sphingolipids as mediators of cell cycle progression, renal disease, and stress responses, and (iv) the involvement of disrupted sphingolipid metabolism in animal disease and cellular deregulation associated with exposure to inhibitors of ceramide synthase and serine palmitoyltransferase, key enzymes in de novo sphingolipid biosynthesis. These findings illustrate how an understanding of the function of sphingolipids can help solve questions in toxicology and this is undoubtedly only the beginning of this story.
AuthorsA H Merrill Jr, E M Schmelz, D L Dillehay, S Spiegel, J A Shayman, J J Schroeder, R T Riley, K A Voss, E Wang
JournalToxicology and applied pharmacology (Toxicol Appl Pharmacol) Vol. 142 Issue 1 Pg. 208-25 (Jan 1997) ISSN: 0041-008X [Print] United States
PMID9007051 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S., Review)
Chemical References
  • Carboxylic Acids
  • Ceramides
  • Dietary Fats
  • Enzyme Inhibitors
  • Growth Substances
  • Membrane Lipids
  • Morpholines
  • Mycotoxins
  • Sphingolipids
  • RV 538
  • Amidohydrolases
  • Ceramidases
  • Calcium
Topics
  • Amidohydrolases (antagonists & inhibitors)
  • Animal Feed
  • Animals
  • Calcium (metabolism)
  • Carboxylic Acids (toxicity)
  • Cell Cycle
  • Cell Division
  • Ceramidases
  • Ceramides (physiology)
  • Dietary Fats
  • Enzyme Inhibitors (pharmacology)
  • Food Contamination
  • Gene Expression Regulation (physiology)
  • Growth Substances (physiology)
  • Homeostasis
  • Humans
  • Mammals (metabolism)
  • Membrane Lipids (chemistry, physiology)
  • Models, Biological
  • Morpholines (pharmacology)
  • Mycotoxins (toxicity)
  • Second Messenger Systems
  • Sphingolipids (chemistry, physiology)
  • Stress, Physiological (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: